Department of Neurology, Clinical Hospital of Psychiatry and Neurology, Prundului street 7-9, Brasov, Romania
Research Article
The Use of MLC901 in Combination with Anticoagulant among an Eastern European Cohort - Real World Data from NeuroAiD Safe Treatment Registry(NeST Registry)
Author(s): Anita Arsovska*, Brola Waldemar, Frasineanu Armand Daniel, Marceanu Manuela, Reisz Daniela, Sarzyńska-Długosz Iwona, Serdahely Vlastimil, Simu Mihaela Adriana, Valkovič Peter and Narayanaswamy Venketasubramanian
Objectives: The efficacy and safety of NeuroAiD™ is well-established in patients with ischemic stroke in the acute and chronic phase. It is an addon treatment to standard therapies and there were no reports of major interactions. However, there is currently no data on the use of NeuroAiDTM in combination with anticoagulants. We aimed to determine the safety of using MLC901 (NeuroAiD II) with anticoagulants among patients in the Eastern European Cohort.
Methods: We performed a subgroup analysis of patients enrolled in the NeuroAiD Safe Treatment Registry (NeST). Patient who were given anticoagulants were included. Data collected were baseline demographics, diagnosis, concomitant medications and adverse events.
Results: A total of 98 patients were included. There were 48 female (49%), median age 64 years IQR (5.. Read More»
DOI:
10.37421/2795-6172.2023.7.182